AMIORG Share Price Today (AMIORG)
TODAY IN ONE LINE
With a market cap of ₹26,850.46 Cr., it trades at a P/E of 43.06. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
AMIORG flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Healthy Operating MarginsOPM is structurally strong at 22.1%
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Low Promoter HoldingPromoters hold only 0.3%
Latest AMIORG News
What changed recently?
Recent events, corporate actions, and announcements.
AMIORG valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for AMIORG, framed against the sector median so the premium or discount is obvious at a glance.
AMIORG trades at a P/E of 43.06× and P/B of 6.82×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
AMIORG technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for AMIORG — derived from the live tape, not yesterday's close.
AMIORG last traded at ₹1,176.3 with an intraday range of ₹1,170.1–₹1,184.8 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹1176.30| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1213.43 | +37.13 | +3.16% |
| R3 | 1198.73 | +22.43 | +1.91% |
| R2 | 1191.77 | +15.47 | +1.31% |
| R1 | 1184.03 | +7.73 | +0.66% |
| PIVOT | 1177.07 | 0.77 | 0.07% |
| CURRENT | 1176.30 | — | — |
| S1 | 1169.33 | -6.97 | -0.59% |
| S2 | 1162.37 | -13.93 | -1.18% |
| S3 | 1154.63 | -21.67 | -1.84% |
| S4 | 1139.93 | -36.37 | -3.09% |
AMIORG is trading Below CPR, indicating Bearishness
CPR is Narrower, suggesting likely for trending moves
Day's range: ₹–₹
Trading Inside opening range
AMIORG financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for AMIORG — consolidated or standalone — with margins, YoY growth and key ratios inline.
AMIORG reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹26,850.46 Cr..
| Metric | Mar 2024 | Mar 2025 |
|---|---|---|
| Revenue from Operations | 717 | 1,007 ▲ 40.3% |
| Sales Growth YoY %Derived | 16.33% | 40.34% |
| Other Income | 7 | 17 ▲ 126.0% |
| Total Income | 725 | 1,024 ▲ 41.2% |
| 412 | 552 ▲ 34.1% | |
| Gross ProfitDerived | 306 | 455 ▲ 48.7% |
| Gross Margin %Derived | 42.62% | 45.16% |
| 177 | 223 ▲ 25.6% | |
| EBITDA (Operating Profit)Derived | 128 | 232 ▲ 80.6% |
| OPM %Derived | 17.91% | 23.05% |
| -10 | 33 ▲ 425.5% | |
| Profit Before Tax (PBT) | 82 | 216 ▲ 163.9% |
| 33 | 56 ▲ 67.9% | |
| Effective Tax %Derived | 40.53% | 25.79% |
| Total Profit for Period | 49 | 160 ▲ 229.3% |
| Less: Non-controlling Interests | 6 | 2 ▼ 71.3% |
| Net Profit (Owner's PAT)Derived | 43 | 159 ▲ 271.1% |
| Net Profit Margin %Derived | 5.96% | 15.76% |
| PAT Growth YoY %Derived | -48.65% | 271.06% |
| Earnings Per Share (EPS ₹) | 5.80 | 19.39 ▲ 234.3% |
| Diluted Shares Outstanding (Cr) | 7 | 8 ▲ 11.0% |
| Other Comprehensive Income (Net of Tax) | -7 | -0 ▲ 98.1% |
| Total Expenses (incl. D&A & Interest) | 611 | 808 ▲ 32.2% |
| Material Cost % of RevenueDerived | 61.35% | 56.59% |
| Employee Cost % of RevenueDerived | 8.80% | 8.31% |
| Other Cost % of RevenueDerived | 15.91% | 13.80% |
| Interest Coverage (x)Derived | 18.93x | 33.04x |
| Period | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Trend |
|---|---|---|---|---|---|
| Revenue from Operations | 520 | 617 ▲ 18.6% | 717 ▲ 16.3% | 1,007 ▲ 40.3% | |
| Sales Growth YoY %Derived | — | 18.57% | 16.33% | 40.34% | |
| Other Income | 3 | 4 ▲ 56.4% | 7 ▲ 73.4% | 17 ▲ 126.0% | |
| Total Income | 523 | 621 ▲ 18.8% | 725 ▲ 16.7% | 1,024 ▲ 41.2% | |
273 | 331 ▲ 21.3% | 412 ▲ 24.4% | 552 ▲ 34.1% | ||
| Gross ProfitDerived | 247 | 286 ▲ 15.6% | 306 ▲ 7.0% | 455 ▲ 48.7% | |
| Gross Margin %Derived | 47.55% | 46.35% | 42.62% | 45.16% | |
142 | 163 ▲ 14.9% | 177 ▲ 8.6% | 223 ▲ 25.6% | ||
| EBITDA (Operating Profit)Derived | 105 | 123 ▲ 16.6% | 128 ▲ 4.8% | 232 ▲ 80.6% | |
| OPM %Derived | 20.22% | 19.88% | 17.91% | 23.05% | |
16 | 15 ▼ 10.5% | -10 ▼ 168.4% | 33 ▲ 425.5% | ||
| Profit Before Tax (PBT) | 91 | 112 ▲ 22.7% | 82 ▼ 27.0% | 216 ▲ 163.9% | |
20 | 29 ▲ 48.1% | 33 ▲ 14.9% | 56 ▲ 67.9% | ||
| Effective Tax %Derived | 21.33% | 25.75% | 40.53% | 25.79% | |
| Total Profit for Period | 72 | 83 ▲ 15.8% | 49 ▼ 41.5% | 160 ▲ 229.3% | |
| Less: Non-controlling Interests | — | — | 6 | 2 ▼ 71.3% | |
| Net Profit (Owner's PAT)Derived | 72 | 83 ▲ 15.8% | 43 ▼ 48.6% | 159 ▲ 271.1% | |
| Net Profit Margin %Derived | 13.83% | 13.50% | 5.96% | 15.76% | |
| PAT Growth YoY %Derived | — | 15.77% | -48.65% | 271.06% | |
| Earnings Per Share (EPS ₹) | 9.87 | 11.43 ▲ 15.8% | 5.80 ▼ 49.3% | 19.39 ▲ 234.3% | |
| Diluted Shares Outstanding (Cr) | 7 | 7 ▲ 0.0% | 7 ▲ 1.2% | 8 ▲ 11.0% | |
| Other Comprehensive Income (Net of Tax) | 2 | 3 ▲ 62.4% | -7 ▼ 335.2% | -0 ▲ 98.1% | |
| Total Expenses (incl. D&A & Interest) | 431 | 509 ▲ 17.9% | 611 ▲ 20.1% | 808 ▲ 32.2% | |
| Material Cost % of RevenueDerived | 54.28% | 56.08% | 61.35% | 56.59% | |
| Employee Cost % of RevenueDerived | 7.95% | 7.92% | 8.80% | 8.31% | |
| Other Cost % of RevenueDerived | 19.37% | 18.55% | 15.91% | 13.80% | |
| Interest Coverage (x)Derived | 14.84x | 45.71x | 18.93x | 33.04x |
AMIORG segment analysis : revenue and profit mix.
Disclosed business segments at AMIORG with their share of revenue and profit, switchable between consolidated and standalone reporting.
AMIORG discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for AMIORG.
Our AI distills the core fundamental drivers supporting AMIORG, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
AMIORG's investment case rests on 2 positive markers and 5 flagged concerns drawn from the latest reported filings.
What you're getting.
The relatively stable stock price over the past five days, fluctuating between approximately 1160 and 1200, suggests potential for future growth, although this needs to be confirmed with more complete financial data.
High daily trading volumes, ranging from 242,994 to 455,735 shares, indicate significant market interest in AMIORG. This could be leveraged to attract further investment if the company addresses its data transparency issues.
Key Risks.
The absence of key financial data, such as the Price-to-Earnings ratio (P/E), Return on Equity (ROE), and Debt-to-Equity ratio, prevents a proper assessment of AMIORG's financial health and profitability. This lack of transparency is a major concern for potential investors.
The reported market capitalization and current stock price are both 0.00, indicating severely incomplete or missing data. This critical data gap makes any meaningful financial analysis impossible and raises serious questions about data reliability.
The provided data lacks crucial information on promoter holdings, leaving investors uncertain about the level of management control and potential risks associated with ownership structure. This opacity is a significant drawback.
The complete absence of essential financial metrics, including profitability ratios and debt levels, presents a significant threat. Without this information, investors cannot accurately assess the company's risk profile and potential for future returns.
The lack of transparency regarding key financial data and promoter holdings creates significant uncertainty and risk for potential investors. This lack of information could deter investment and negatively impact the company's valuation.
Flip Conditions.
Valuation risk. a P/E above 56 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 0.02%.
AMIORG peer comparison — same-sector benchmarks.
No comparable peer set was disclosed for AMIORG.
Peer comparison data is not available.
AMIORG chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for AMIORG — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
AMIORG delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for AMIORG over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in AMIORG stood at 69.1% of traded volume, against a 20-day average of 52.0%.
AMIORG announcements: results, concalls, ratings, M&A.
Filings AMIORG sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
No filings or concall transcripts on record.
AMIORG dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue AMIORG has declared, sequenced by announce and record date.
AMIORG corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About AMIORG: business, sector, key facts.
What AMIORG does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
AMIORG is a listed Indian equity.
AMIORG
Acutaas Chemicals Limited (formerly Ami Organics Limited) is a prominent player in the pharmaceutical and specialty chemical industry, headquartered in Surat, India. Their core business revolves around the research, development, manufacturing, and global distribution of pharmaceutical intermediates. These intermediates serve as crucial building blocks in the synthesis of a wide range of active pharmaceutical ingredients (APIs).
A significant portion of Acutaas's pharmaceutical intermediate production caters to the creation of APIs for various therapeutic applications. This includes anti-retroviral drugs used to combat HIV/AIDS, anti-inflammatory medications for reducing swelling and pain, anti-psychotics for managing mental illnesses, anti-cancer agents for treating malignancies, anti-Parkinson's drugs to alleviate Parkinson's disease symptoms, antidepressants used to treat depression, and anticoagulants to prevent blood clots. Furthermore, they contribute to the development of new chemical entities (NCEs), representing cutting-edge advancements in pharmaceutical research.
Beyond the pharmaceutical sector, Acutaas Chemicals Limited also manufactures and supplies specialty chemicals to other industries. These include agrochemicals (for agriculture), cosmetics (for beauty and personal care products), and polymers (used in various materials). Specific examples of these specialty chemicals include parabens (preservatives), salicylic acid (used in various applications), and other specialized compounds employed in cosmetics, dyes, polymers, agrochemicals, animal feed, and personal care products.
The company boasts a substantial export business, distributing its pharmaceutical intermediates and specialty chemicals to customers across the globe. Its history dates back to 2004, demonstrating a long-standing commitment to innovation and quality within the chemical manufacturing sector. The name change to Acutaas Chemicals Limited occurred in May 2025, signifying a potential rebranding or strategic shift in the company's focus, although the core business activities remain largely unchanged.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Stocks near 52-week high (breakout watch)Screener
- Breakout Trader strategy playbookStrategy
- Stocks near 52-week low (reversal watch)Screener
- Reversal Hunter strategy playbookStrategy
- Other overvalued NSE stocksScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about this stock (AMIORG).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of this stock (AMIORG)?
The current share price of this stock (AMIORG) is ₹1,176.3. Today, the stock has declined by ₹3.60 (0.31%), trading in a range of ₹1,170.1 to ₹1,184.8. The stock opened at ₹1,179.9 with a trading volume of 2,42,994 shares.
02Is this stock stock a good investment for long-term?
this stock can be considered for long-term investment based on several factors. The company has a market capitalization of ₹26,850.46 crores, P/E ratio of 43.06, ROE of 12.15%, and ROCE of 0.00%. The dividend yield stands at 0.04%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of this stock stock?
The 52-week high price of this stock (AMIORG) is ₹1,194.2, while the 52-week low is ₹1,170.1. Currently trading at ₹1,176.3, the stock is 25.7% away from its 52-week low and 1.5% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy this stock stock at the current price?
Whether to buy this stock stock at ₹1,176.3 depends on multiple factors. The stock is currently trading with a P/E ratio of 43.06 and P/B ratio of 6.82. Today's performance shows a loss of 0.31%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of this stock and when is the next dividend?
this stock offers a dividend yield of 0.04%, which means for every ₹100 invested at the current price of ₹1,176.3, you can expect to receive approximately ₹0.04 annually as dividends. The face value of the stock is ₹0.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of this stock?
this stock's key financial metrics include: P/E Ratio: 43.06, P/B Ratio: 6.82, ROE: 12.15%, ROCE: 0.00%, Dividend Yield: 0.04%, EPS: ₹0.00, Book Value: ₹0, and Debt-to-Equity: 0.01. The company's market cap stands at ₹26,850.46 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is this stock stock performing today in the market?
this stock stock opened at ₹1,179.9 and is currently trading at ₹1,176.3, showing a decline of ₹3.60 (0.31%). The intraday high is ₹1,184.8 and low is ₹1,170.1. The trading volume stands at 2,42,994 shares, indicating moderate market participation today.
08What is the P/E ratio of this stock and what does it indicate?
this stock has a Price-to-Earnings (P/E) ratio of 43.06, which means investors are willing to pay ₹43.06 for every ₹1 of earnings. With an EPS of ₹0.00, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about the company (AMIORG) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.